https://ogma.newcastle.edu.au/vital/access/ /manager/Index en-au 5 Adjuvant Therapy of Nivolumab Combined with Ipilimumab Versus Nivolumab Alone in Patients with Resected Stage IIIB-D or Stage IV Melanoma (CheckMate 915) https://ogma.newcastle.edu.au/vital/access/ /manager/Repository/uon:50584 Wed 28 Feb 2024 15:06:35 AEDT ]]> Modelled economic evaluation of nivolumab for the treatment of second-line advanced or metastatic squamous non-small-cell lung cancer in Australia using both partition survival and markov models https://ogma.newcastle.edu.au/vital/access/ /manager/Repository/uon:47631 Tue 24 Jan 2023 14:23:51 AEDT ]]> Esophageal chemoradiotherapy with concurrent nivolumab: Pilot results in the palliative treatment of oligometastatic disease https://ogma.newcastle.edu.au/vital/access/ /manager/Repository/uon:55855 Tue 02 Jul 2024 15:10:51 AEST ]]> Immunotherapy-induced sarcoidosis in patients with melanoma treated with PD-1 checkpoint inhibitors: Case series and immunophenotypic analysis https://ogma.newcastle.edu.au/vital/access/ /manager/Repository/uon:34826 Thu 13 Jan 2022 10:31:11 AEDT ]]>